14 drug(s) with this reaction
1,982 total reports
Dysgeusia has been reported as an adverse reaction across 14 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,982 adverse event reports mention dysgeusia in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with dysgeusia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have dysgeusia listed in their FDA adverse event reports, sorted by report count:
In addition to dysgeusia, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
14 drug(s) manufactured by Haleon Us Holdings Llc have dysgeusia listed in their FDA adverse event reports: IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, NICOTINE POLACRILEX, NICOTINE, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, and others.
There are a combined 1,982 reports of dysgeusia across 14 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.